{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:30:14Z","timestamp":1772721014082,"version":"3.50.1"},"reference-count":195,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic lupus erythematosus (SLE) is a complex autoimmune disorder of unknown etiology that is influenced by environmental and genetic factors. The disease is associated with severe clinical manifestations, including renal involvement, skin, nervous system, and cardiovascular system complications. Given the severity of these symptoms, there is a need for effective treatments with minimal side effects. Current treatments, such as corticosteroids, result in significant adverse outcomes and show limited efficacy. As a result, new therapeutic approaches are being investigated. Among these, cell-based therapies, especially stem cell therapy, have attracted attention due to the immunomodulatory and regenerative properties of stem cells. However, several challenges limit the clinical success of mesenchymal stem cell (MSC) therapies. These challenges include lack of targeted transduction, limited survival and proliferation of transplanted cells, and difficulties in maintaining therapeutic properties and function. To overcome these limitations and improve efficacy, strategies for modifying MSCs have been developed, such as genetic engineering via gene therapy, nanotechnology-based drug delivery systems to enhance targeting and homing, and pretreatment of MSCs with anti-inflammatory agents or compounds that enhance survival and migration. This review explores strategies for modifying MSCs to enhance their therapeutic potential in the treatment of systemic lupus erythematosus.<\/jats:p>","DOI":"10.1093\/mr\/roaf112","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:08:52Z","timestamp":1763557732000},"page":"163-180","source":"Crossref","is-referenced-by-count":1,"title":["Modified mesenchymal stem cells as an innovative therapeutic approach in systemic lupus erythematosus: A comprehensive review"],"prefix":"10.1093","volume":"36","author":[{"given":"Zahra","family":"Jafari","sequence":"first","affiliation":[{"name":"Student Research Committee, Department of Immunology, School of Medicine, Zanjan University of Medical Sciences , Zanjan ,","place":["Iran"]},{"name":"Department of Immunology, School of Medicine, Zanjan University of Medical Sciences , Zanjan ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Hamzehpour","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine, Karaj Branch, Islamic Azad University , Karaj ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Faghihi","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine, Tabriz Branch, Islamic Azad University , Tabriz ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Arab Derazi","sequence":"additional","affiliation":[{"name":"Student Research Committee, Department of Immunology, School of Medicine, Zanjan University of Medical Sciences , Zanjan ,","place":["Iran"]},{"name":"Department of Immunology, School of Medicine, Zanjan University of Medical Sciences , Zanjan ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Hassanzadeh Makoui","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine, Zanjan University of Medical Sciences , Zanjan ,","place":["Iran"]},{"name":"Cancer Gene Therapy Research Center (CGRC), Zanjan University of Medical Sciences , Zanjan ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Hassanzadeh Makoui","sequence":"additional","affiliation":[{"name":"Department of Cardiology, School of Medicine, Zanjan University of Medical Sciences , Zanjan ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Fekri","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Zanjan University of Medical Sciences , Zanjan ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negar","family":"Ansari","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Zanjan University of Medical Sciences , Zanjan ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6355-6378","authenticated-orcid":false,"given":"Seyyed Shamsadin","family":"Athari","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine, Zanjan University of Medical Sciences , Zanjan ,","place":["Iran"]},{"name":"Cancer Gene Therapy Research Center (CGRC), Zanjan University of Medical Sciences , Zanjan ,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"key":"2026030508165693600_ref1","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"2026030508165693600_ref2","doi-asserted-by":"crossref","first-page":"Itc81","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"key":"2026030508165693600_ref3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-med-043021-032611","article-title":"Systemic lupus erythematosus: new diagnostic and therapeutic approaches","volume":"74","author":"Lazar","year":"2023","journal-title":"Annu Rev Med"},{"key":"2026030508165693600_ref4","doi-asserted-by":"crossref","first-page":"8815","DOI":"10.1002\/jcp.26795","article-title":"Key genes and functional coexpression modules involved in the pathogenesis of systemic lupus erythematosus","volume":"233","author":"Yan","year":"2018","journal-title":"J Cell Physiol"},{"key":"2026030508165693600_ref5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2026030508165693600_ref6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrneph.2017.85","article-title":"Redefining lupus nephritis: clinical implications of pathophysiologic subtypes","volume":"13","author":"Yu","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2026030508165693600_ref7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.rdc.2021.04.001","article-title":"Interferons in systemic lupus erythematosus","volume":"47","author":"Sirobhushanam","year":"2021","journal-title":"Rheum Dis Clin N Am"},{"key":"2026030508165693600_ref8","first-page":"84","article-title":"Bio-inspired adhesive porous particles with human MSCs encapsulation for systemic lupus erythematosus treatment","volume":"6","author":"Nie","year":"2021","journal-title":"Bioact Mater"},{"key":"2026030508165693600_ref9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41584-020-0374-8","article-title":"Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology","volume":"16","author":"Broen","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2026030508165693600_ref10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12016-021-08898-7","article-title":"The therapeutic strategies for SLE by targeting anti-dsDNA antibodies","volume":"63","author":"Wang","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"2026030508165693600_ref11","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191911895","article-title":"Diet and systemic lupus erythematosus (SLE): from supplementation to intervention","volume":"19","author":"Jiao","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2026030508165693600_ref12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"2026030508165693600_ref13","doi-asserted-by":"crossref","first-page":"749192","DOI":"10.3389\/fimmu.2021.749192","article-title":"Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases","volume":"12","author":"Shen","year":"2021","journal-title":"Front Immunol"},{"key":"2026030508165693600_ref14","doi-asserted-by":"crossref","first-page":"394917","DOI":"10.1155\/2015\/394917","article-title":"Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications","volume":"2015","author":"Castro-Manrreza","year":"2015","journal-title":"J Immunol Res"},{"key":"2026030508165693600_ref15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.exphem.2009.01.005","article-title":"Mesenchymal stem cells suppress B-cell terminal differentiation","volume":"37","author":"Asari","year":"2009","journal-title":"Exp Hematol"},{"key":"2026030508165693600_ref16","doi-asserted-by":"crossref","first-page":"10007","DOI":"10.1038\/s41598-019-46316-3","article-title":"Human menstrual blood-derived stromal\/stem cells modulate functional features of natural killer cells","volume":"9","author":"Shokri","year":"2019","journal-title":"Sci Rep"},{"key":"2026030508165693600_ref17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/stem.2575","article-title":"Concise review: MSC-derived exosomes for cell-free therapy","volume":"35","author":"Phinney","year":"2017","journal-title":"Stem Cells"},{"key":"2026030508165693600_ref18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0961203317711013","article-title":"Bone marrow-derived mesenchymal stem cells inhibit T follicular helper cell in lupus-prone mice","volume":"27","author":"Yang","year":"2018","journal-title":"Lupus."},{"key":"2026030508165693600_ref19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/scrt216","article-title":"Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells","volume":"4","author":"Luz-Crawford","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"2026030508165693600_ref20","doi-asserted-by":"crossref","first-page":"728190","DOI":"10.3389\/fimmu.2021.728190","article-title":"Mesenchymal stem cell therapy: hope for patients with systemic lupus erythematosus","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"2026030508165693600_ref21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13287-025-04184-x","article-title":"Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Zeng","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"2026030508165693600_ref22","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.ymthe.2025.02.003","article-title":"Mesenchymal stromal cell therapy: progress to date and future outlook","volume":"33","author":"Lu","year":"2025","journal-title":"Mol Ther"},{"key":"2026030508165693600_ref23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.addr.2007.08.035","article-title":"Genetic modification of stem cells for transplantation","volume":"60","author":"Phillips","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"2026030508165693600_ref24","doi-asserted-by":"crossref","first-page":"e96161","DOI":"10.1371\/journal.pone.0096161","article-title":"Conditioned medium from hypoxic bone marrow-derived mesenchymal stem cells enhances wound healing in mice","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"2026030508165693600_ref25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/0022034514557671","article-title":"Effects of hypoxia on the immunomodulatory properties of human gingiva\u2013derived mesenchymal stem cells","volume":"94","author":"Jiang","year":"2015","journal-title":"J Dent Res"},{"key":"2026030508165693600_ref26","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.nano.2015.05.008","article-title":"Thermo-responsive polymeric nanoparticles for enhancing neuronal differentiation of human induced pluripotent stem cells","volume":"11","author":"Seo","year":"2015","journal-title":"Nanomedicine"},{"key":"2026030508165693600_ref27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246231","article-title":"B Cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments","volume":"20","author":"Yap","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026030508165693600_ref28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12865-020-00388-3","article-title":"Assessing the expression of immunosuppressive cytokines in the newly diagnosed systemic lupus erythematosus patients: a focus on B cells","volume":"21","author":"Abbasifard","year":"2020","journal-title":"BMC Immunol"},{"key":"2026030508165693600_ref29","volume-title":"American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus (SLE): Guideline Summary 2025","author":"American College of Rheumatology","year":"2025"},{"key":"2026030508165693600_ref30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26030929","article-title":"Advances in targeted therapy for systemic lupus erythematosus: current treatments and novel approaches","volume":"26","author":"Saegusa","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2026030508165693600_ref31","first-page":"7948687","article-title":"Research progress on regulatory B cells in systemic lupus erythematosus","volume":"2019","author":"Wang","year":"2019","journal-title":"Biomed Res Int"},{"key":"2026030508165693600_ref32","doi-asserted-by":"crossref","first-page":"104930","DOI":"10.4252\/wjsc.v17.i8.104930","article-title":"Advances in mesenchymal stem cell therapy for lupus nephritis","volume":"17","author":"Liu","year":"2025","journal-title":"World J Stem Cells"},{"key":"2026030508165693600_ref33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2478\/jtim-2022-0028","article-title":"Mesenchymal stem cells and connective tissue diseases: from bench to bedside","volume":"11","author":"Shi","year":"2023","journal-title":"J Transl Int Med"},{"key":"2026030508165693600_ref34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s41232-024-00348-z","article-title":"Adipose-derived mesenchymal stem cell therapy for connective tissue diseases and complications","volume":"44","author":"Kotani","year":"2024","journal-title":"Inflamm Regen"},{"key":"2026030508165693600_ref35","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/stem.3016","article-title":"Concise review: Mesenchymal stem cells: from roots to boost","volume":"37","author":"Andrzejewska","year":"2019","journal-title":"Stem Cells"},{"key":"2026030508165693600_ref36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.critrevonc.2013.12.002","article-title":"Human umbilical cord blood-derived stromal cells: a new source of stromal cells in hematopoietic stem cell transplantation","volume":"90","author":"Liu","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026030508165693600_ref37","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/jcmm.12839","article-title":"hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine","volume":"20","author":"Sabapathy","year":"2016","journal-title":"J Cell Mol Med"},{"key":"2026030508165693600_ref38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2026030508165693600_ref39","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150025","article-title":"Human mesenchymal stem cells - current trends and future prospective","volume":"35","author":"Ullah","year":"2015","journal-title":"Biosci Rep"},{"key":"2026030508165693600_ref40","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-025-02313-9","article-title":"Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies","volume":"10","author":"Han","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"2026030508165693600_ref41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4252\/wjsc.v2.i4.67","article-title":"Mesenchymal stem cells: molecular characteristics and clinical applications","volume":"2","author":"Rastegar","year":"2010","journal-title":"World J Stem Cells"},{"key":"2026030508165693600_ref42","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.100249","article-title":"Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta-analysis","volume":"19","author":"Thompson","year":"2020","journal-title":"EClinicalMedicine."},{"key":"2026030508165693600_ref43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2026030508165693600_ref44","doi-asserted-by":"crossref","first-page":"130763","DOI":"10.1155\/2013\/130763","article-title":"Mesenchymal stem cells migration homing and tracking","volume":"2013","author":"Sohni","year":"2013","journal-title":"Stem Cells Int"},{"key":"2026030508165693600_ref45","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3389\/fimmu.2019.01645","article-title":"Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application","volume":"10","author":"Caplan","year":"2019","journal-title":"Front Immunol"},{"key":"2026030508165693600_ref46","doi-asserted-by":"crossref","first-page":"114263","DOI":"10.1016\/j.yexcr.2024.114263","article-title":"Influence of mesenchymal stem cells from different origins on the therapeutic effectiveness of systemic lupus erythematosus","volume":"442","author":"Yuan","year":"2024","journal-title":"Exp Cell Res"},{"key":"2026030508165693600_ref47","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001197","article-title":"Metabolomic analysis suggests thiamine monophosphate as a potential marker for mesenchymal stem cell transplantation outcomes in patients with SLE","volume":"12","author":"Jiang","year":"2025","journal-title":"Lupus Sci Med"},{"key":"2026030508165693600_ref48","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s13287-022-03174-7","article-title":"Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17(+) regulatory T cell","volume":"13","author":"Zhang","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"2026030508165693600_ref49","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030508165693600_ref50","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaut.2007.02.005","article-title":"Clearance deficiency and systemic lupus erythematosus (SLE)","volume":"28","author":"Gaipl","year":"2007","journal-title":"J Autoimmun"},{"key":"2026030508165693600_ref51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.autrev.2017.11.018","article-title":"NK cells in autoimmune diseases: linking innate and adaptive immune responses","volume":"17","author":"Gianchecchi","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2026030508165693600_ref52","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.1916897117","article-title":"Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus","volume":"117","author":"Goel","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030508165693600_ref53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","article-title":"Immunological pathogenesis and treatment of systemic lupus erythematosus","volume":"16","author":"Pan","year":"2020","journal-title":"World J Pediatr"},{"key":"2026030508165693600_ref54","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41409-019-0616-z","article-title":"Mesenchymal stem cell-derived exosomes for clinical use","volume":"54","author":"Mendt","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"2026030508165693600_ref55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.clim.2011.01.004","article-title":"Regulation of acute graft-versus-host disease by human umbilical cord blood derived stromal cells in haploidentical stem cell transplantation in mice through very late activation antigen-4","volume":"139","author":"Zhang","year":"2011","journal-title":"Clin Immunol"},{"key":"2026030508165693600_ref56","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood."},{"key":"2026030508165693600_ref57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.imlet.2007.04.001","article-title":"IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells","volume":"110","author":"English","year":"2007","journal-title":"Immunol Lett"},{"key":"2026030508165693600_ref58","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","article-title":"Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells","volume":"109","author":"Sato","year":"2007","journal-title":"Blood."},{"key":"2026030508165693600_ref59","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/154732804323099190","article-title":"Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells","volume":"13","author":"Zhang","year":"2004","journal-title":"Stem Cells Dev"},{"key":"2026030508165693600_ref60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1634\/stemcells.2007-0416","article-title":"Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche","volume":"26","author":"Raffaghello","year":"2008","journal-title":"Stem Cells"},{"key":"2026030508165693600_ref61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/scd.2014.0155","article-title":"Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells","volume":"24","author":"Rosado","year":"2015","journal-title":"Stem Cells Dev"},{"key":"2026030508165693600_ref62","doi-asserted-by":"crossref","first-page":"637725","DOI":"10.3389\/fcell.2021.637725","article-title":"Immunomodulatory properties of mesenchymal stromal cells: an update","volume":"9","author":"M\u00fcller","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026030508165693600_ref63","doi-asserted-by":"crossref","first-page":"e12712","DOI":"10.1111\/cpr.12712","article-title":"Immune modulation by mesenchymal stem cells","volume":"53","author":"Jiang","year":"2020","journal-title":"Cell Prolif"},{"key":"2026030508165693600_ref64","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","article-title":"Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation","volume":"107","author":"Spaggiari","year":"2006","journal-title":"Blood"},{"key":"2026030508165693600_ref65","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/art.40396","article-title":"Abnormal B cell development in systemic lupus erythematosus: what the genetics tell us","volume":"70","author":"Karrar","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2026030508165693600_ref66","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T cell metabolism: a new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol"},{"key":"2026030508165693600_ref67","doi-asserted-by":"crossref","first-page":"385297","DOI":"10.1155\/2014\/385297","article-title":"Effect of proinflammatory cytokines (IL-6, TNF-\u03b1, and IL-1\u03b2) on clinical manifestations in Indian SLE patients","volume":"2014","author":"Umare","year":"2014","journal-title":"Mediat Inflamm"},{"key":"2026030508165693600_ref68","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"key":"2026030508165693600_ref69","doi-asserted-by":"crossref","first-page":"e1801","DOI":"10.6061\/clinics\/2020\/e1801","article-title":"Serum interleukin-6 level is correlated with the disease activity of systemic lupus erythematosus: a meta-analysis","volume":"75","author":"Ding","year":"2020","journal-title":"Clinics (Sao Paulo)"},{"key":"2026030508165693600_ref70","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions","volume":"107","author":"Corcione","year":"2006","journal-title":"Blood"},{"key":"2026030508165693600_ref71","doi-asserted-by":"crossref","first-page":"237","DOI":"10.15283\/ijsc20001","article-title":"SOCS1 regulates the immunomodulatory roles of MSCs on B cells","volume":"13","author":"Zhang","year":"2020","journal-title":"Int J Stem Cells"},{"key":"2026030508165693600_ref72","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","article-title":"Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells","volume":"105","author":"Glennie","year":"2005","journal-title":"Blood"},{"key":"2026030508165693600_ref73","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3324\/haematol.11240","article-title":"Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction","volume":"92","author":"Prevosto","year":"2007","journal-title":"Haematologica"},{"key":"2026030508165693600_ref74","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/stem.3185","article-title":"Mesenchymal stromal cells induce regulatory T cells via epigenetic conversion of human conventional CD4 T cells in vitro","volume":"38","author":"Azevedo","year":"2020","journal-title":"Stem Cells"},{"key":"2026030508165693600_ref75","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.gene.2017.06.012","article-title":"Mesenchymal stem cells can induce regulatory T cells via modulating miR-126a but not miR-10a","volume":"627","author":"Khosravi","year":"2017","journal-title":"Gene"},{"key":"2026030508165693600_ref76","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13287-020-02057-z","article-title":"Regulatory T cell induction by mesenchymal stem cells depends on the expression of TNFR2 by T cells","volume":"11","author":"Naserian","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"2026030508165693600_ref77","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/stem.3151","article-title":"Effects of mesenchymal stromal cells on regulatory T cells: current understanding and clinical relevance","volume":"38","author":"Negi","year":"2020","journal-title":"Stem Cells"},{"key":"2026030508165693600_ref78","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/ajt.17001","article-title":"Mesenchymal stem cells augment regulatory T cell function via CD80-mediated interactions and promote allograft survival","volume":"22","author":"Mittal","year":"2022","journal-title":"Am J Transplant"},{"key":"2026030508165693600_ref79","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113006","article-title":"Mesenchymal stem cell induced Foxp3(+) Tregs suppress effector T cells and protect against retinal ischemic injury","volume":"10","author":"Agrawal","year":"2021","journal-title":"Cells"},{"key":"2026030508165693600_ref80","article-title":"Mesenchymal stem\/stromal cell-based therapies in systemic rheumatic disease: from challenges to new approaches for overcoming restrictions","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026030508165693600_ref81","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15283\/ijsc.2015.8.1.54","article-title":"New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation","volume":"8","author":"Kim","year":"2015","journal-title":"Int J Stem Cells"},{"key":"2026030508165693600_ref82","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/j.1582-4934.2011.01509.x","article-title":"Immunogenicity of allogeneic mesenchymal stem cells","volume":"16","author":"Schu","year":"2012","journal-title":"J Cell Mol Med"},{"key":"2026030508165693600_ref83","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cpr.12012","article-title":"Mesenchymal stem cell transfusion for desensitization of positive lymphocyte cross-match before kidney transplantation: outcome of 3 cases","volume":"46","author":"Saadi","year":"2013","journal-title":"Cell Prolif"},{"key":"2026030508165693600_ref84","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat Biotechnol"},{"key":"2026030508165693600_ref85","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.52225\/narra.v4i3.994","article-title":"Mesenchymal stem cells for immune modulation in systemic lupus erythematosus: from bench research to clinical applications","volume":"4","author":"Ginting","year":"2024","journal-title":"Narra J"},{"key":"2026030508165693600_ref86","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12916-023-02923-6","article-title":"Detrimental alteration of mesenchymal stem cells by an articular inflammatory microenvironment results in deterioration of osteoarthritis","volume":"21","author":"Fan","year":"2023","journal-title":"BMC Med"},{"key":"2026030508165693600_ref87","doi-asserted-by":"crossref","first-page":"151041","DOI":"10.1016\/j.ejcb.2019.04.002","article-title":"Mesenchymal stem cell therapy for the treatment of inflammatory diseases: challenges, opportunities, and future perspectives","volume":"98","author":"Regmi","year":"2019","journal-title":"Eur J Cell Biol"},{"key":"2026030508165693600_ref88","doi-asserted-by":"crossref","DOI":"10.3390\/ph17030350","article-title":"An overview of mesenchymal stem cell heterogeneity and concentration","volume":"17","author":"Mali\u010dev","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026030508165693600_ref89","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13578-024-01219-3","article-title":"Unveiling the functional heterogeneity of cytokine-primed human umbilical cord mesenchymal stem cells through single-cell RNA sequencing","volume":"14","author":"Hu","year":"2024","journal-title":"Cell Biosci"},{"key":"2026030508165693600_ref90","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/stmcls\/sxac043","article-title":"MHC class I enables MSCs to evade NK-cell-mediated cytotoxicity and exert immunosuppressive activity","volume":"40","author":"Oh","year":"2022","journal-title":"Stem Cells"},{"key":"2026030508165693600_ref91","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/wound.2011.0314","article-title":"Mesenchymal stem cells home to sites of injury and inflammation","volume":"1","author":"Rustad","year":"2012","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"2026030508165693600_ref92","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000124281","article-title":"In vitro differentiation potential of mesenchymal stem cells","volume":"35","author":"Gimble","year":"2008","journal-title":"Transfus Med Hemother"},{"key":"2026030508165693600_ref93","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12015-014-9495-2","article-title":"Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation","volume":"10","author":"Sivanathan","year":"2014","journal-title":"Stem Cell Rev Rep"},{"key":"2026030508165693600_ref94","doi-asserted-by":"crossref","first-page":"a015560","DOI":"10.1101\/cshperspect.a015560","article-title":"Mesenchymal stromal cells in transplantation rejection and tolerance","volume":"3","author":"English","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026030508165693600_ref95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02234-x","article-title":"Improved therapeutics of modified mesenchymal stem cells: an update","volume":"18","author":"Ocansey","year":"2020","journal-title":"J Transl Med"},{"key":"2026030508165693600_ref96","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.spinee.2012.12.005","article-title":"The effects of microenvironment in mesenchymal stem cell\u2013based regeneration of intervertebral disc","volume":"13","author":"Huang","year":"2013","journal-title":"Spine J"},{"key":"2026030508165693600_ref97","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jcyt.2016.09.003","article-title":"Genetically modified mesenchymal stromal cells in cancer therapy","volume":"18","author":"Sage","year":"2016","journal-title":"Cytotherapy"},{"key":"2026030508165693600_ref98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2015.03.002","article-title":"Engineering mesenchymal stem cells for regenerative medicine and drug delivery","volume":"84","author":"Park","year":"2015","journal-title":"Methods"},{"key":"2026030508165693600_ref99","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12015-017-9760-2","article-title":"Gene delivery approaches for mesenchymal stem cell therapy: strategies to increase efficiency and specificity","volume":"13","author":"Oggu","year":"2017","journal-title":"Stem Cell Rev Rep"},{"key":"2026030508165693600_ref100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat Rev Genet"},{"key":"2026030508165693600_ref101","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13287-023-03295-7","article-title":"Research progress of engineered mesenchymal stem cells and their derived exosomes and their application in autoimmune\/inflammatory diseases","volume":"14","author":"Zhu","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"2026030508165693600_ref102","first-page":"1","article-title":"Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies","volume":"10","author":"Noronha","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"2026030508165693600_ref103","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/jcmm.13492","article-title":"Preconditioning influences mesenchymal stem cell properties in vitro and in vivo","volume":"22","author":"Hu","year":"2018","journal-title":"J Cell Mol Med"},{"key":"2026030508165693600_ref104","doi-asserted-by":"crossref","first-page":"e2395","DOI":"10.1038\/cddis.2016.310","article-title":"Hypoxia-induced expression of cellular prion protein improves the therapeutic potential of mesenchymal stem cells","volume":"7","author":"Han","year":"2016","journal-title":"Cell Death Dis"},{"key":"2026030508165693600_ref105","doi-asserted-by":"crossref","first-page":"e10733","DOI":"10.1002\/jbm4.10733","article-title":"Hypoxia inducible factor 2\u03b1 signaling in the skeletal system","volume":"7","author":"Mendoza","year":"2023","journal-title":"JBMR Plus"},{"key":"2026030508165693600_ref106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40778-023-00232-5","article-title":"First clinical experiences using preconditioning approaches to improve MSC-based therapies","volume":"10","author":"Le","year":"2024","journal-title":"Curr Stem Cell Rep"},{"key":"2026030508165693600_ref107","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","article-title":"Challenges, progress, and prospects of developing therapies to treat autoimmune diseases","volume":"181","author":"Fugger","year":"2020","journal-title":"Cell"},{"key":"2026030508165693600_ref108","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/stem.2948","article-title":"Concise review: Exploring immunomodulatory features of mesenchymal stromal cells in humanized mouse models","volume":"37","author":"Mehler","year":"2019","journal-title":"Stem Cells"},{"key":"2026030508165693600_ref109","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0963689719837897","article-title":"The pros and cons of mesenchymal stem cell-based therapies","volume":"28","author":"Musia\u0142-Wysocka","year":"2019","journal-title":"Cell Transplant"},{"key":"2026030508165693600_ref110","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.177.4.2080","article-title":"Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells","volume":"177","author":"Nauta","year":"2006","journal-title":"J Immunol"},{"key":"2026030508165693600_ref111","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1634\/stemcells.2006-0548","article-title":"Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism","volume":"25","author":"Djouad","year":"2007","journal-title":"Stem Cells"},{"key":"2026030508165693600_ref112","doi-asserted-by":"crossref","first-page":"37566","DOI":"10.1038\/srep37566","article-title":"Umbilical cord-derived mesenchymal stem cells instruct monocytes towards an IL10-producing phenotype by secreting IL6 and HGF","volume":"6","author":"Deng","year":"2016","journal-title":"Sci Rep"},{"key":"2026030508165693600_ref113","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer\u2013cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2, 3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"key":"2026030508165693600_ref114","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1634\/stemcells.2008-0687","article-title":"Reciprocal interactions between human mesenchymal stem cells and \u03b3\u03b4 T cells or invariant natural killer T cells","volume":"27","author":"Prigione","year":"2009","journal-title":"Stem Cells"},{"key":"2026030508165693600_ref115","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","article-title":"Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+ CD25highFOXP3+ regulatory T cells","volume":"26","author":"Selmani","year":"2008","journal-title":"Stem Cells"},{"key":"2026030508165693600_ref116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrrheum.2016.197","article-title":"IL-23 assists the transition from autoimmunity to inflammatory disease","volume":"13","author":"Villanueva","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"2026030508165693600_ref117","first-page":"32","article-title":"Hydrophobic interaction-a mechanism of bacterial binding","volume":"33","author":"Magnusson","year":"1982","journal-title":"Scand J Infect Dis Suppl"},{"key":"2026030508165693600_ref118","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1016\/j.biomaterials.2012.03.065","article-title":"Stem cell membrane engineering for cell rolling using peptide conjugation and tuning of cell\u2013selectin interaction kinetics","volume":"33","author":"Cheng","year":"2012","journal-title":"Biomaterials"},{"key":"2026030508165693600_ref119","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.1016\/j.biomaterials.2013.07.033","article-title":"The use of surface immobilization of P-selectin glycoprotein ligand-1 on mesenchymal stem cells to facilitate selectin mediated cell tethering and rolling","volume":"34","author":"Lo","year":"2013","journal-title":"Biomaterials"},{"key":"2026030508165693600_ref120","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1182\/blood-2010-10-311464","article-title":"Engineered cell homing","volume":"118","author":"Sarkar","year":"2011","journal-title":"Blood"},{"key":"2026030508165693600_ref121","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1016\/j.biomaterials.2014.07.041","article-title":"Engineering of cell membranes with a bisphosphonate-containing polymer using ATRP synthesis for bone targeting","volume":"35","author":"D'Souza","year":"2014","journal-title":"Biomaterials"},{"key":"2026030508165693600_ref122","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/14653249.2010.542458","article-title":"Bone marrow mesenchymal stromal cells with support of bispecific antibody and ultrasound-mediated microbubbles prevent myocardial fibrosis via the signal transducer and activators of transcription signaling pathway","volume":"13","author":"Deng","year":"2011","journal-title":"Cytotherapy"},{"key":"2026030508165693600_ref123","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1038\/am.2017.171","article-title":"Novel biomaterial strategies for controlled growth factor delivery for biomedical applications","volume":"9","author":"Wang","year":"2017","journal-title":"NPG Asia Materials"},{"key":"2026030508165693600_ref124","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41536-021-00160-0","article-title":"Matrilin3\/TGF\u03b23 gelatin microparticles promote chondrogenesis, prevent hypertrophy, and induce paracrine release in MSC spheroid for disc regeneration","volume":"6","author":"Bello","year":"2021","journal-title":"npj Regener Med"},{"key":"2026030508165693600_ref125","doi-asserted-by":"crossref","first-page":"e0128963","DOI":"10.1371\/journal.pone.0128963","article-title":"Stability, intracellular delivery, and release of siRNA from chitosan nanoparticles using different cross-linkers","volume":"10","author":"Abdul Ghafoor Raja","year":"2015","journal-title":"PLoS One"},{"key":"2026030508165693600_ref126","doi-asserted-by":"crossref","first-page":"100190","DOI":"10.1016\/j.mtbio.2021.100190","article-title":"Microtissues from mesenchymal stem cells and siRNA-loaded cross-linked gelatin microparticles for bone regeneration","volume":"13","author":"Hinkelmann","year":"2022","journal-title":"Mater Today Bio"},{"key":"2026030508165693600_ref127","doi-asserted-by":"crossref","first-page":"34560","DOI":"10.1021\/acsami.9b04769","article-title":"Polymer microparticles with defined surface chemistry and topography mediate the formation of stem cell aggregates and cardiomyocyte function","volume":"11","author":"Alvarez-Paino","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"2026030508165693600_ref128","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.3390\/ijms22052491","article-title":"Applications of biomaterials in 3D cell culture and contributions of 3D cell culture to drug development and basic biomedical research","volume":"22","author":"Park","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026030508165693600_ref129","first-page":"38","article-title":"Hydrogel scaffolds for tissue engineering: progress and challenges","volume":"2013","author":"El-Sherbiny","year":"2013","journal-title":"Glob Cardio Sci Prac"},{"key":"2026030508165693600_ref130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jare.2013.07.006","article-title":"Hydrogel: preparation, characterization, and applications: a review","volume":"6","author":"Ahmed","year":"2015","journal-title":"J Adv Res"},{"key":"2026030508165693600_ref131","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/gels3010006","article-title":"Hydrogels for biomedical applications: their characteristics and the mechanisms behind them","volume":"3","author":"Chai","year":"2017","journal-title":"Gels"},{"key":"2026030508165693600_ref132","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40824-023-00371-0","article-title":"Progress and emerging techniques for biomaterial-based derivation of mesenchymal stem cells (MSCs) from pluripotent stem cells (PSCs)","volume":"27","author":"Prakash","year":"2023","journal-title":"Biomater Res"},{"key":"2026030508165693600_ref133","article-title":"Immunomodulatory mechanisms of mesenchymal stem cells and their potential clinical applications","volume":"23","author":"Huang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026030508165693600_ref134","doi-asserted-by":"crossref","first-page":"e67790","DOI":"10.1371\/journal.pone.0067790","article-title":"Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"2026030508165693600_ref135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1681\/ASN.2019050545","article-title":"Additive therapeutic effects of mesenchymal stem cells and IL-37 for systemic lupus erythematosus","volume":"31","author":"Xu","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2026030508165693600_ref136","doi-asserted-by":"crossref","first-page":"13249","DOI":"10.1021\/acsnano.4c02420","article-title":"Dexamethasone-integrated mesenchymal stem cells for systemic lupus erythematosus treatment via multiple immunomodulatory mechanisms","volume":"18","author":"Ma","year":"2024","journal-title":"ACS Nano"},{"key":"2026030508165693600_ref137","first-page":"860","article-title":"Immunomodulatory mechanism of umbilical cord mesenchymal stem cells modified by miR-125b-5p in systemic lupus erythematosus","volume":"56","author":"Wu","year":"2024","journal-title":"Beijing Da Xue Xue Bao"},{"key":"2026030508165693600_ref138","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s13287-023-03578-z","article-title":"A new generation of mesenchymal stromal\/stem cells differentially trained by immunoregulatory probiotics in a lupus microenvironment","volume":"14","author":"Hoseinzadeh","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"2026030508165693600_ref139","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10753-024-02092-5","article-title":"Dimethyloxallyl glycine preconditioning promotes the anti-inflammatory and anti-fibrotic effects of human umbilical cord mesenchymal stem cells on kidney damage in systemic lupus erythematosus related to TGF-\u03b2\/Smad signaling pathway","volume":"48","author":"Ning","year":"2025","journal-title":"Inflammation"},{"key":"2026030508165693600_ref140","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1400347","article-title":"The issue of heterogeneity of MSC-based advanced therapy medicinal products\u2013a review","volume":"12","author":"\u010cesnik","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"2026030508165693600_ref141","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","article-title":"Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo","volume":"17","author":"Friedenstein","year":"1974","journal-title":"Transplantation"},{"key":"2026030508165693600_ref142","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1182\/blood.V98.8.2396","article-title":"Identification of mesenchymal stem\/progenitor cells in human first-trimester fetal blood, liver, and bone marrow","volume":"98","author":"Campagnoli","year":"2001","journal-title":"Blood"},{"key":"2026030508165693600_ref143","first-page":"845","article-title":"Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential","volume":"88","author":"in't Anker","year":"2003","journal-title":"Haematologica"},{"key":"2026030508165693600_ref144","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1177\/0963689717721203","article-title":"Impact of age on human adipose stem cells for bone tissue engineering","volume":"26","author":"Dufrane","year":"2017","journal-title":"Cell Transplant"},{"key":"2026030508165693600_ref145","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1177\/0963689717721221","article-title":"Adipose-derived mesenchymal stem cells from the elderly exhibit decreased migration and differentiation abilities with senescent properties","volume":"26","author":"Liu","year":"2017","journal-title":"Cell Transplant"},{"key":"2026030508165693600_ref146","first-page":"464","article-title":"Commentary on: Adipose stem cell function maintained with age: an intra-subject study of long-term cryopreserved cells","volume":"37","author":"Irizarry","year":"2016","journal-title":"Aesthet Surg J"},{"key":"2026030508165693600_ref147","doi-asserted-by":"crossref","first-page":"464","DOI":"10.5966\/sctm.2015-0161","article-title":"Obesity determines the immunophenotypic profile and functional characteristics of human mesenchymal stem cells from adipose tissue","volume":"5","author":"Pach\u00f3n-Pe\u00f1a","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"2026030508165693600_ref148","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"2026030508165693600_ref149","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3727\/096368915X689622","article-title":"Clinical trials with mesenchymal stem cells: an update","volume":"25","author":"Squillaro","year":"2016","journal-title":"Cell Transplant"},{"key":"2026030508165693600_ref150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.918565","article-title":"Optimization of mesenchymal stromal cell (MSC) manufacturing processes for a better therapeutic outcome","volume":"13","author":"Fern\u00e1ndez-Santos","year":"2022","journal-title":"Front Immunol"},{"key":"2026030508165693600_ref151","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/bab.1006","article-title":"Large-scale production of human mesenchymal stem cells for clinical applications","volume":"59","author":"Jung","year":"2012","journal-title":"Biotechnol Appl Biochem"},{"key":"2026030508165693600_ref152","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jcyt.2016.05.012","article-title":"Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow-derived multipotent mesenchymal stromal cells","volume":"18","author":"Codinach","year":"2016","journal-title":"Cytotherapy"},{"key":"2026030508165693600_ref153","doi-asserted-by":"crossref","first-page":"90554","DOI":"10.5500\/wjt.v14.i2.90554","article-title":"Controversies regarding transplantation of mesenchymal stem cells","volume":"14","author":"Velikova","year":"2024","journal-title":"World J Transplant"},{"key":"2026030508165693600_ref154","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jbiotec.2009.08.008","article-title":"Alginate encapsulation technology supports embryonic stem cells differentiation into insulin-producing cells","volume":"144","author":"Wang","year":"2009","journal-title":"J Biotechnol"},{"key":"2026030508165693600_ref155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.lfs.2015.11.007","article-title":"Application of encapsulation technology in stem cell therapy","volume":"143","author":"Hashemi","year":"2015","journal-title":"Life Sci"},{"key":"2026030508165693600_ref156","doi-asserted-by":"crossref","DOI":"10.3390\/cells14030149","article-title":"Mesenchymal stem\/stromal cells microencapsulation for cell therapy","volume":"14","author":"Abbas","year":"2025","journal-title":"Cells"},{"key":"2026030508165693600_ref157","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.37275\/bsm.v9i4.1244","article-title":"Immunomodulatory effects of mesenchymal stem cell secretome in systemic lupus erythematosus: a meta-analysis","volume":"9","author":"Kusuma","year":"2025","journal-title":"Bioscmed"},{"key":"2026030508165693600_ref158","doi-asserted-by":"crossref","first-page":"9149315","DOI":"10.1155\/2021\/9149315","article-title":"Clinical efficacy and safety of human mesenchymal stem cell therapy for degenerative disc disease: a systematic review and meta-analysis of randomized controlled trials","volume":"2021","author":"Xie","year":"2021","journal-title":"Stem Cells Int"},{"key":"2026030508165693600_ref159","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.2147\/DDDT.S269407","article-title":"Challenges for mesenchymal stem cell-based therapy for COVID-19","volume":"14","author":"Li","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"2026030508165693600_ref160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-021-01037-x","article-title":"Challenges and advances in clinical applications of mesenchymal stromal cells","volume":"14","author":"Zhou","year":"2021","journal-title":"J Hematol Oncol"},{"key":"2026030508165693600_ref161","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13287-017-0503-8","article-title":"Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model","volume":"8","author":"Joswig","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"2026030508165693600_ref162","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s13287-021-02609-x","article-title":"The safety of MSC therapy over the past 15 years: a meta-analysis","volume":"12","author":"Wang","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"2026030508165693600_ref163","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ymthe.2022.08.011","article-title":"Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs","volume":"31","author":"Crippa","year":"2023","journal-title":"Mol Ther"},{"key":"2026030508165693600_ref164","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41467-020-14977-8","article-title":"A CRISPR-Cas9-based reporter system for single-cell detection of extracellular vesicle-mediated functional transfer of RNA","volume":"11","author":"Jong","year":"2020","journal-title":"Nat Commun"},{"key":"2026030508165693600_ref165","doi-asserted-by":"crossref","first-page":"101454","DOI":"10.1016\/j.nantod.2022.101454","article-title":"ECM-inspired peptide dendrimer microgels with human MSCs encapsulation for systemic lupus erythematosus treatment","volume":"43","author":"Zhu","year":"2022","journal-title":"Nano Today"},{"key":"2026030508165693600_ref166","doi-asserted-by":"crossref","first-page":"e1319","DOI":"10.1002\/iid3.1319","article-title":"Combined application of mesenchymal stem cells and different glucocorticoid dosing alleviates osteoporosis in SLE murine models","volume":"12","author":"Ding","year":"2024","journal-title":"Immun Inflamm Dis"},{"key":"2026030508165693600_ref167","doi-asserted-by":"crossref","first-page":"i22","DOI":"10.1093\/rheumatology\/keac678","article-title":"Dilemma of immunosuppression and infection risk in systemic lupus erythematosus","volume":"62","author":"He","year":"2023","journal-title":"Rheumatology"},{"key":"2026030508165693600_ref168","first-page":"39","article-title":"Towards precision medicine in systemic lupus erythematosus","volume":"13","author":"Lever","year":"2020","journal-title":"Pharmgenomics Pers Med"},{"key":"2026030508165693600_ref169","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1741-7015-11-146","article-title":"Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells","volume":"11","author":"Siegel","year":"2013","journal-title":"BMC Med"},{"key":"2026030508165693600_ref170","doi-asserted-by":"crossref","first-page":"111539","DOI":"10.1016\/j.mad.2021.111539","article-title":"Age-related alterations and senescence of mesenchymal stromal cells: implications for regenerative treatments of bones and joints","volume":"198","author":"Zupan","year":"2021","journal-title":"Mech Ageing Dev"},{"key":"2026030508165693600_ref171","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/annrheumdis-2012-eular.3142","article-title":"SAT0195\u00a0Impact of mycophenolate mofetil and\/or corticosteroid treatment on outcomes of belimumab treatment in SLE","volume":"71","author":"Schneider","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2026030508165693600_ref172","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/acr.22971","article-title":"Effects of belimumab on flare rate and expected damage progression in patients with active systemic lupus erythematosus","volume":"69","author":"Iaccarino","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2026030508165693600_ref173","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/annrheumdis-2021-eular.1471","article-title":"OP0131\u00a0Anifrolumab effects on rash and arthritis in patients with SLE and Impact of interferon signal In Pooled data from phase 3 trials","volume":"80","author":"Merrill","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2026030508165693600_ref174","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.25011\/cim.v46i1.39561","article-title":"Efficacy of mesenchymal stem cell therapy on lupus nephritis and renal function in systemic lupus erythematosus: a meta-analysis","volume":"46","author":"Xia","year":"2023","journal-title":"Clin Invest Med"},{"key":"2026030508165693600_ref175","doi-asserted-by":"crossref","first-page":"9463314","DOI":"10.1155\/2022\/9463314","article-title":"Efficacy and safety of mesenchymal stem cell transplantation in the treatment of autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, and ankylosing spondylitis): a systematic review and meta-analysis of randomized controlled trial","volume":"2022","author":"Zeng","year":"2022","journal-title":"Stem Cells Int"},{"key":"2026030508165693600_ref176","article-title":"Mesenchymal Stem Cells Infusion in Patients with Autoimmune Diseases - a Phase II Clinical Trial [Internet]","year":"2025"},{"key":"2026030508165693600_ref177","article-title":"Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus Nephritis [Internet]","year":"2024"},{"key":"2026030508165693600_ref178","article-title":"A Multicenter Phase I\/II Clinical Trial To Evaluate the Safety, Tolerability, and Efficacy of RY_SW01cell Injection Therapy in Active Lupus Nephritis [Internet]","year":"2023"},{"key":"2026030508165693600_ref179","article-title":"A Prospective Single-Center Study of Comparing the Efficacy and Safety of Human Umbilical Cord Mesenchymal Stem Cells and Low-Dose IL-2 in the Treatment of Lupus Nephritis","year":"2022"},{"key":"2026030508165693600_ref180","article-title":"Phase II Double-Blind, Placebo-Controlled Clinical Trial To Evaluate Safety and Efficacy of Mesenchymal Stem Cells (MSV-Allo) in the Treatment of Lupus Nephritis","year":"2018"},{"key":"2026030508165693600_ref181","article-title":"24-Week investigator Study To Evaluate the Efficacy and Safety of CS20AT04 (HLA-Haplo Matched Allogenic Bone Marrow-Derived Stem Cells) Administered in Patients with Lupus Nephritis or Lupus Cytopenia [Internet]","author":"Open-label","year":"2021"},{"key":"2026030508165693600_ref182","article-title":"Treatment of Systemic Lupus Erythematosus with Pooled Allogenic Olfactory Mucosa Derived Mesenchymal Stem Cells [Internet]","year":"2019"},{"key":"2026030508165693600_ref183","article-title":"Treatment of Refractory Systemic Lupus Erythematosus by Injection of Allogeneic Mesenchymal Stem Cells Derived from the Umbilical Cord [Internet]","year":"2018"},{"key":"2026030508165693600_ref184","article-title":"A Randomized Double-Blind, Parallel-Controlled, Multi-Center Study To Evaluate the Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells in Patients with Lupus Nephritis [Internet]","year":"2018"},{"key":"2026030508165693600_ref185","article-title":"A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus [Internet]","year":"2015"},{"key":"2026030508165693600_ref186","article-title":"Clinical Study of Umbilical Cord Mesenchymal Stem Cell Transplantation for Lupus Nephritis [Internet]","year":"2018"},{"key":"2026030508165693600_ref187","article-title":"Long-Term Follow-up for Safety Evaluation of Subjects Who Participated in the Phase 1 Clinical Trial of CS20AT04 (CS20AT04-LN101) in Lupus Nephritis [Internet]","year":"2020"},{"key":"2026030508165693600_ref188","article-title":"Evaluation of Safety and Efficacy in Patients with Systemic Lupus Erythematosus by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells [Internet]","year":"2017"},{"key":"2026030508165693600_ref189","article-title":"A Phase 1 Study to Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis [Internet]","year":"2017"},{"key":"2026030508165693600_ref190","article-title":"A Phase I Safety Trial of Allogeneic Mesenchymal Stem Cells for Systemic Lupus Erythematosus [Internet]","year":"2017"},{"key":"2026030508165693600_ref191","article-title":"Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis [Internet]","year":"2020"},{"key":"2026030508165693600_ref192","article-title":"Phase I\/II: Umbilical Cord Derived Mesenchymal Stem Cells Transplantation For Active And Refractory Systemic Lupus Erythematosus [Internet]","year":"2012"},{"key":"2026030508165693600_ref193","article-title":"A Randomized Double Blind, Parallel Group, Placebo Controlled Research of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis [Internet]","year":"2012"},{"key":"2026030508165693600_ref194","article-title":"Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis [Internet]","year":"2008"},{"key":"2026030508165693600_ref195","article-title":"Phase I\/IIa: Allogeneic Bone Marrow Derived Mesenchymal Stem Cells Transplantation For Refractory Systemic Lupus Erythematosus [Internet]","year":"2008"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roaf112\/65467606\/roaf112.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/36\/2\/163\/65467606\/roaf112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/36\/2\/163\/65467606\/roaf112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T13:17:28Z","timestamp":1772716648000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/36\/2\/163\/8340152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":195,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11,22]]},"published-print":{"date-parts":[[2026,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/roaf112","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,11,22]]}}}